Headquartered in Nashville, Embold Health leverages its proprietary advanced analytics and unparalleled data to help employers, patients and payors identify high-performing doctors and health systems in markets across the United States.  In doing so, the Company is uniquely positioned to address the approximately $750 billion of inappropriate or unnecessary care provided each year in the United States.

Said Daniel Stein, M.D., Founder and CEO of Embold Health, "We appreciate Harpeth Capital's ability to efficiently complete this growth capital infusion that will allow us to capitalize on significant opportunities in the pipeline in 2019 and beyond.  They successfully leveraged the firm’s relationships and introduced us to experienced healthcare investors who understand our mission and will be valuable partners as we grow."

Visit www.emboldhealth.com for additional information.